India's Lupin Plant Slapped with a Form 483

Feb 24, 2015

Reuters

The U.S. FDA has issued Lupin a Form 483, listing six concerns of its production processes at a plant that produces both oral contraceptives and treatments for eye diseases for sale in the United States in Pithampur in central India.

According to a Reuters article, the FDA inspected the plant in January this year, after which it issued the company a Form 483. Lupin didn't disclose the nature of the observations. Read the full article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments